PURPOSE: To investigate the relationship between changes in vascularity and metabolic activity measured by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and dynamic (18)F-FDG-positron emission tomography (PET) in breast tumors undergoing neoadjuvant chemotherapy. MATERIALS AND METHODS: PET and MRI examinations were performed in 14 patients with locally advanced breast cancer (LABC) before and after chemotherapy. Dynamic (18)F-FDG PET measures included (18)F-FDG transport rate constant from blood to tissue (K(1)) and metabolism flux constant (Ki). DCE-MRI measures included initial peak enhancement (PE), signal enhancement ratio (SER), and tumor volume. Spearman rank-order correlations were assessed between changes in PET and MRI parameters, and measures were compared between patients with and without pathologic complete response (pCR) by Mann-Whitney U-test. RESULTS: Changes in glucose delivery (PET K(1)) were closely correlated with changes in tumor vascularity as reflected by DCE-MRI SER (r = 0.83, P < 0.001). Metabolic changes in PET Ki showed moderate correlations with vascularity changes as reflected by SER (r = 0.71) and PE (r = 0.76), and correlated closely with MRI tumor volume (r = 0.79, P < 0.001). Decreases in K(1), Ki, SER, and PE were greater for patients with pCR compared to those with residual disease (P < 0.05). CONCLUSION: Dynamic (18)F-FDG PET and DCE-MRI tumor measures of tumor metabolism, vascularity, and volume were well correlated for assessing LABC response to neoadjuvant chemotherapy and significantly discriminated pathologic complete responders. Further work is necessary to assess the value of combined PET and MRI for evaluating tumor pharmacodynamics in response to novel therapy.
PURPOSE: To investigate the relationship between changes in vascularity and metabolic activity measured by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and dynamic (18)F-FDG-positron emission tomography (PET) in breast tumors undergoing neoadjuvant chemotherapy. MATERIALS AND METHODS: PET and MRI examinations were performed in 14 patients with locally advanced breast cancer (LABC) before and after chemotherapy. Dynamic (18)F-FDG PET measures included (18)F-FDG transport rate constant from blood to tissue (K(1)) and metabolism flux constant (Ki). DCE-MRI measures included initial peak enhancement (PE), signal enhancement ratio (SER), and tumor volume. Spearman rank-order correlations were assessed between changes in PET and MRI parameters, and measures were compared between patients with and without pathologic complete response (pCR) by Mann-Whitney U-test. RESULTS: Changes in glucose delivery (PET K(1)) were closely correlated with changes in tumor vascularity as reflected by DCE-MRI SER (r = 0.83, P < 0.001). Metabolic changes in PET Ki showed moderate correlations with vascularity changes as reflected by SER (r = 0.71) and PE (r = 0.76), and correlated closely with MRI tumor volume (r = 0.79, P < 0.001). Decreases in K(1), Ki, SER, and PE were greater for patients with pCR compared to those with residual disease (P < 0.05). CONCLUSION: Dynamic (18)F-FDG PET and DCE-MRI tumor measures of tumor metabolism, vascularity, and volume were well correlated for assessing LABC response to neoadjuvant chemotherapy and significantly discriminated pathologic complete responders. Further work is necessary to assess the value of combined PET and MRI for evaluating tumor pharmacodynamics in response to novel therapy.
Authors: Savannah C Partridge; Jessica E Gibbs; Ying Lu; Laura J Esserman; Debasish Tripathy; Dulcy S Wolverton; Hope S Rugo; E Shelley Hwang; Cheryl A Ewing; Nola M Hylton Journal: AJR Am J Roentgenol Date: 2005-06 Impact factor: 3.959
Authors: Garry M McDermott; Andrew Welch; Roger T Staff; Fiona J Gilbert; Lutz Schweiger; Scott I K Semple; Tim A D Smith; Andrew W Hutcheon; Iain D Miller; Ian C Smith; Steven D Heys Journal: Breast Cancer Res Treat Date: 2006-08-09 Impact factor: 4.872
Authors: M Reivich; D Kuhl; A Wolf; J Greenberg; M Phelps; T Ido; V Casella; J Fowler; E Hoffman; A Alavi; P Som; L Sokoloff Journal: Circ Res Date: 1979-01 Impact factor: 17.367
Authors: Jeffrey Tseng; Lisa K Dunnwald; Erin K Schubert; Jeanne M Link; Satoshi Minoshima; Mark Muzi; David A Mankoff Journal: J Nucl Med Date: 2004-11 Impact factor: 10.057
Authors: David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Aaron Charlop; Thomas J Lawton; Erin K Schubert; Jeffrey Tseng; Robert B Livingston Journal: J Nucl Med Date: 2002-04 Impact factor: 10.057
Authors: Scott I K Semple; Fiona J Gilbert; Thomas W Redpath; Roger T Staff; Trevor S Ahearn; Andrew E Welch; Steven D Heys; Andrew W Hutcheon; Elizabeth H Smyth; Shailesh Chaturvedi Journal: Eur Radiol Date: 2004-08-14 Impact factor: 5.315
Authors: Anwar R Padhani; Carmel Hayes; Laura Assersohn; Trevor Powles; Andreas Makris; John Suckling; Martin O Leach; Janet E Husband Journal: Radiology Date: 2006-03-16 Impact factor: 11.105
Authors: Elizabeth M C Hillman; Cyrus B Amoozegar; Tracy Wang; Addason F H McCaslin; Matthew B Bouchard; James Mansfield; Richard M Levenson Journal: Philos Trans A Math Phys Eng Sci Date: 2011-11-28 Impact factor: 4.226
Authors: Kenneth E Pengel; Bas B Koolen; Claudette E Loo; Wouter V Vogel; Jelle Wesseling; Esther H Lips; Emiel J Th Rutgers; Renato A Valdés Olmos; Marie Jeanne T F D Vrancken Peeters; Sjoerd Rodenhuis; Kenneth G A Gilhuijs Journal: Eur J Nucl Med Mol Imaging Date: 2014-04-29 Impact factor: 9.236
Authors: Nazia F Jafri; David C Newitt; John Kornak; Laura J Esserman; Bonnie N Joe; Nola M Hylton Journal: J Magn Reson Imaging Date: 2013-12-18 Impact factor: 4.813
Authors: Vito Amoroso; Daniele Generali; Thomas Buchholz; Massimo Cristofanilli; Rebecca Pedersini; Giuseppe Curigliano; Maria Grazia Daidone; Serena Di Cosimo; Mitchell Dowsett; Stephen Fox; Adrian L Harris; Andreas Makris; Lucia Vassalli; Andrea Ravelli; Maria Rosa Cappelletti; Christos Hatzis; Clifford A Hudis; Paolo Pedrazzoli; Anna Sapino; Vladimir Semiglazov; Gunter Von Minckwitz; Edda L Simoncini; Michael A Jacobs; Peter Barry; Thorsten Kühn; Sarah Darby; Kerstin Hermelink; Fraser Symmans; Alessandra Gennari; Gaia Schiavon; Luigi Dogliotti; Alfredo Berruti; Alberto Bottini Journal: J Natl Cancer Inst Monogr Date: 2015-05